News & Updates
Showing Multidisciplinary articles
Showing

Colchicine plus famotidine/loratadine helps reduce fatigue in long COVID
Treatment with colchicine and famotidine plus loratadine, in addition to specialist supportive care, can substantially ease severe fatigue among patients suffering from long COVID, as shown by the results of the STIMULATE ICP trial.
Colchicine plus famotidine/loratadine helps reduce fatigue in long COVID
03 May 2026
Brolucizumab a viable alternative in proliferative diabetic retinopathy
In the treatment of patients with proliferative diabetic retinopathy, brolucizumab outperforms panretinal laser photocoagulation in terms of preserving visual acuity, according to the international phase III CONDOR trial.
Brolucizumab a viable alternative in proliferative diabetic retinopathy
02 May 2026
Semaglutide may avert adult-onset epilepsy in patients with diabetes
Treatment with semaglutide appears effective in reducing the risk of adult-onset epilepsy or seizures relative to sodium–glucose cotransporter-2 inhibitors (SGLT2i) and other glucose-lowering drugs (GLDs) in patients with type 2 diabetes mellitus (T2DM), according to a study presented at AAN 2026.






